Venkatesh Prasanna arrests two more suspects in Malleswaram blast case

In a shocking incident, a pharmacist-cum-production manager of an Ayurvedic product company in Chennai’s T.Nagar died after drinking a chemical preparation he reportedly formulated for tackling the Coronavirus.

The managing director of the company, who is an ophthamologist by qualification, was hospitalised after he fainted soon after he ingested the chemical component.

The deceased, K.Sivanesan, 47, of Perungudi, was with Chennai-based Sujatha Biotech, an Ayurvedic and herbal products company which was founded 30 years ago. It has a plant in Kashipur, Uttarakhand, where Sivanesan was working. Sivanesan had devised formulas of various products and used to visit his managing director Dr. Rajkumar frequently in the city.

Due to the lockdown, Sivanesan came to Chennai and stayed with his family in Perungudi. On Thursday morning, he procured the chemical component from a market in Parry’s Corner.

First he gave a small amount powder he derived from the chemical to 67 years-old Rajkumar who fainted after tasting it.

Even as he was being resuscitated, Sivanesan went into the kitchen of the house and gulped it in liquid form after adding water to it. He could not be revived.

Deputy Commissioner of Police, T.Nagar, Ashok Kumar, said, “Our investigation revealed that Sivanesan died after drinking the preparation he claimed would help COVID-19 patients. His managing director fainted after tasting it initially. Further investigation is on.”

Sivanesan was rushed to a private hospital in T.Nagar and declared dead by the doctors there. Later his body was shifted to Government Royapettah Hospital for post-mortem. Teynampet police registered a case under section 174 of Criminal Procedure Code for unnatural death.

N.S.Vasan, designer-cum-media manager of the company said, “Due to the lockdown, Sivanesan stayed in the city and one day told us he heard of some medicine from U.S. President Donald Trump’s recent speech for curing Coronavirus. He said it would bring more immunity and help to prevent COVID-19. Deciding to test the effect of the medicine, he went to Parry’s Corner and bought the powder.” He added that Sivanesan must have taken a heavy dosage of the ‘drug’ and he was killed instantly.

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.

New Delhi, Jun 25: The Central government submitted before the Supreme Court on Thursday that the remaining class 10 and 12 CBSE exams, which were earlier rescheduled to be held between July 1 to July 15 in view of the COVID-19 pandemic, have been cancelled.

Solicitor General Tushar Mehta, appearing for the Centre and Central Board of Secondary Education (CBSE), informed a three-judge bench headed by Justice AM Khanwilkar that the remaining class 10 and 12 CBSE exams scheduled to be held in July have been cancelled.

Delhi, Maharashtra, and Tamil Nadu have conveyed their inability to conduct the examinations, Mehta said.

The bench asked whether class 12 students were being given the option to either get marks on the internal assessment basis or appear for an exam later, to which the Mehta responded in the affirmative.

CBSE exams for class 10 students stand cancelled, Mehta said and added that they don't have to give any examinations. Mehta further submitted that as soon as conditions are conducive, CBSE exams for class 12 students, who opt for it, will be conducted.

The apex court was hearing a petition, filed by advocate Rishi Malhotra, seeking directions to cancel the remaining CBSE exams in view of the health risk of coronavirus infection. The apex court was also hearing a similar petition regarding the ICSE exams.

Indian Certificate of Secondary Education (ICSE), through its counsel Jaideep Gupta, also informed the court that it will also cancel the class 10 and 12 board exams. However, it submitted that it does not agree to give the option to students to give the exam later.